UnsubscribeHere’s the stock symbol I’ve promised (From Stansberry Research)

SpaceX: Love the Company, But the Stock Is a Harder Call

Written by Thomas Hughes

SpaceX (NASDAQ: SPCX) is a great company to follow and love, being well-positioned in the global race to commercialize space. It provides numerous opportunities for humanity and investors, but now may not be the best time to buy the stock.

Still suffering from its post-IPO malaise, the market shows signs of a bottom but has yet to confirm it. In the current scenario, SPCX is just as likely to continue its downtrend as to recover, and there is more impetus to sell than to buy.

Critical details from the initial earnings report include cash burn: SpaceX literally fuels its rockets with cash and is firing more rockets at a faster pace each quarter. In this environment, short sellers are a risk that cannot be ignored, and early signs suggest they are leaning into the trade.

MarketBeat’s data reveal that short interest as of July 15 was low but has risen steadily since the IPO and is on track to continue rising until another catalyst emerges.

SpaceX Has Great Quarter, But Cash Burn Still a Problem

SpaceX had a great quarter with growth across all segments. Systemwide, revenue increased by 92% year-over-year to outpace the consensus by nearly a billion dollars. The $7.8 billion reported was 1,300 basis points better than expected, underpinned by strength in AI.

AI grew by more than 200% and Connectivity by 66%, making them the two largest and most important segments. At nearly 88% of net revenue, they make the “Space” in SpaceX almost an afterthought, one that is sucking profits out of the other two segments.

Margin details highlight the importance of Connectivity, the single largest segment, to the near-term outlook and AI to the long term. Connectivity, which includes Starlink, is the only profitable segment, and its profitability has so far been insufficient to offset losses in the others.

The good news is that the AI segment losses are tied to data center capacity that is coming online over the next few months and quarters. It will at least begin generating profits within the foreseeable future, while the Space segment may burn cash indefinitely.

Guidance was optimistic, but presents a hurdle for the market. The company says it’s on track to hit a $100 billion annual run rate by year-end, and $1 trillion in annual revenue by 2030. These guidance updates signal that the capacity ramp is progressing smoothly, but now the company has to hit those targets. The risk is that targets won’t be met and profits won’t impress, given the high expectations and ongoing cash burn. CFO Bret Johnson says capital expenditures (CapEx) will run at a similarly high pace in upcoming quarters, well above what market forecasts had initially predicted.

Analyst Optimism May Not Be Enough to Support Price Action

Analysts are optimistic about SpaceX’s future and show high conviction, with 39 analysts tracked. They rate the stock as a Moderate Buy with 72% Buy-side bias and triple-digit upside potential, but may begin to temper their outlook, given the increased expectation for cash burn.

In this scenario, a downshift in analyst sentiment could send the SPCX market into freefall, with the stock not recovering until earnings traction is regained. Institutions are likewise a risk, as they may sit on the sidelines until SpaceX offers them an incentive to buy, and spending money isn’t the way to do it.

The Risks SpaceX Bulls Are Underestimating

SpaceX’s biggest risk lies in its valuation. Even with the post-IPO sell-off, the company is valued at over $1.4 trillion, with the market pricing in robust growth. Assuming SpaceX can execute its strategy, scale launches, and drive margins, the stock trades at pennies on the dollar relative to 2035’s consensus estimate. However, the forecast is predicated on flawless execution, leaving the stock at precariously high valuations today. At recent prices, the stock could shed another 50% and still be highly valued. There is upside potential for this market, but the risks far outweigh the rewards.

What SpaceX bulls underestimate comes down to a handful of costs and risks: the immense expense of space development, the company’s parallel AI buildout, the drag that thin profitability puts on market dynamics, and the insider lockups set to expire on a staggered schedule. Those lockups are the sharpest near-term risk—they open the door tobillions in insider sales with the first tranche unlocking alongside the Q2 earnings report.

Additionally, uncertain profitability is a barrier for institutional ownership, specifically indices such as the S&P 500, which influence trillions in underlying investment dollars. S&P Dow Jones denied the company early approval, choosing instead to enforce the 12-month listing and GAAP profitability requirements. READ THIS STORY ONLINE

Buy this stock tomorrow (Ad)

Marc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership with Nvidia – one he believes positions it ahead of Tesla in the autonomous vehicle race.

With a market-moving announcement expected on July 31st, Chaikin is urging investors to swap overpriced AI stocks for this under-the-radar name before markets open. He’s also releasing a free Hotlist and Hitlist of buy and sell ideas for the second half of 2026.GET THE TICKER SYMBOL AND FULL DETAILS AT NO CHARGE TODAY

Ulta’s Growth Is Real, But So Are the Risks

Written by Peter Frank

Ulta Beauty (NASDAQ: ULTA) has proven to Wall Street that it can grow faster than expected. Now it needs to convince investors to stop worrying.

The beauty retailer has spent years proving to be one of the steadier growth stories in the discretionary retail sector. Its latest quarter did little to change that. Net sales were up, comparable sales showed strength, and income rose.

Despite the results, though, lingering concerns about margin pressure and a tougher macro backdrop leave the stock caught between being a premium growth brand and a market that is pricing with caution.

These days, that split might be more important to investors than headline numbers.

Beauty Remains a Resilient Retail Category

In many ways, Ulta is in the right segment of the consumer discretionary sector. Despite its “discretionary” nature, however, beauty spending has proven to be one of the steadier corners of retail, even as other consumer categories have struggled. By building a hybrid of stores and e-commerce, the company then fashions strong customer loyalty by offering prestige, mass-market, and salon services under one umbrella.

The combination has delivered a resilient business with an operating model that leverages repeat visits even when broader retail outlets suffer.

Quarterly Results Beat Expectations

The most recent numbers support the strategy. Results for Ulta’s first fiscal quarter ended May 2 showed net sales of $3.16 billion, up 11.1% and above analyst expectations. Comparable sales rose 5.3%, up considerably from 2.9% growth a year earlier. The company said the higher results were driven by slightly more transactions and a 3.7% increase in average ticket levels.

At the same time, operating income grew 11.6% to $448.3 million, or 14.2% of net sales. Overall, for the three months, net income came in at $340 million, while diluted earnings per share jumped 15.5% to $7.74 from $6.70 and well above the $6.89 analysts had penciled in.

The first quarter also followed a previously strong showing. In the fourth quarter of its 2026 fiscal year, Ulta posted net sales of $3.9 billion, also ahead of what analysts expected, with earnings per share of $8.01 and net sales up 11.8% year-over-year. For all of fiscal 2025, net sales reached about $12.4 billion.

Guidance Raised Questions About Margins

What set the company back on its heels, however, came in March when Ulta guided full-year earnings per share to a range of $28.05 to $28.55, with the midpoint slightly below what analysts expected.

The company also showed that its operating margin had declined from the prior year, and it cited concerns on a conference call about “global conflicts” and their potential impact on consumer behavior and costs.

Part of the pressure came from increased promotional intensity across the beauty sector, the company said, and increased spending on digital advertising. A newly launched TikTok presence was at the forefront of its marketing initiatives.

“This new channel positions Ulta Beauty at the center of a critical discovery point and will enable us to spotlight our exclusive brands, build influence, and fuel our marketing efforts, particularly with younger consumers.” Ulta’s CEO explained during the first quarter’s conference call.

Shares fell more than 20% on the generally disappointing news as investors digested rising costs and margin pressures.

Margins and Outlook Improved

To that end, the margin story in the latest results might have helped calm some fears. Gross profit in the three months increased 13.8% to about $1.27 billion in the quarter, and gross margin expanded to 40.1% of net sales from 39.1% a year earlier. This quarter, the company said its margin benefited from lower shrinkage, or missing inventory, and stronger merchandise margin.

Management also projected a level of confidence by returning $555 million to shareholders through share buybacks during the quarter. That came after repurchases of $890.5 million during 2025. Ulta does not pay a dividend.

In addition, guidance for the full year was updated and lifted by June 2 when it announced first-quarter earnings. The company now expects diluted earnings per share to range from $28.36 to $28.80 for the current year, representing earnings per share growth of 10.6% to 12.3%.

Valuation Reflects Cautious Optimism

The stock’s valuation reflects much of this twin story of growth and uncertainty. Ulta recently traded around $544 per share, well off its 52-week high of $714.97 but still comfortably above its 52-week low of $443.60. Although down 11% from the start of the year, shares are up about 17% in the past month.

With a trailing price-to-earnings ratio (P/E) near 20 and no dividend yield, the stock has come down from its peak at the end of last year. Still, it will need to actively win over the market before it can climb back toward a P/E of 24 or so.

Overall, analysts rate Ulta a Moderate Buy, with one listing it as a Strong Buy, 19 recommending Buy, six with a neutral Hold rating, and one suggesting Sell. With a consensus 12-month target of $638.09 per share, the current upside is more than 18% at recent prices. The highest target among analysts is $800, while the lowest is $450.

Competition Remains a Key Risk

Beyond the potentially higher costs, fluctuating margins, and macroeconomic trends, competition adds another layer of risk to watch. Ulta’s advantage has always been its breadth, offering a wide range of brands under one roof. But big-box retailers and department stores have poured money into beauty, while direct-to-consumer and social-driven brands pull shoppers toward brand-specific sites.

Competitors are plentiful, like Sephora, mass-market retailers like Walmart (NASDAQ: WMT), department stores like Macy’s (NYSE: M), and online retailers like Amazon (NASDAQ: AMZN).

Even so, given its long growth history, Ulta remains a stock to consider for anyone seeking exposure to a retail brand that has outperformed, is growing in the double digits, and has shown it can attract loyal customers. The beauty category is not guaranteed, but it has stickiness that keeps consumers coming back. READ THIS STORY ONLINE

Here’s the stock symbol I’ve promised (Ad)

Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding – but now he believes he’s found something better.

This under-the-radar company sits at the intersection of America’s two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free – no credit card or email required.GET THE STOCK NAME AND TICKER SYMBOL FREE OF CHARGE TODAY

BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story

Written by Jeffrey Neal Johnson

The artificial intelligence (AI)revolution is running into a severe physical roadblock: the electrical grid. Data centers consume extraordinary amounts of electricity, and tech giantsare scrambling to secure reliable, carbon-free baseload power. Wind and solar lack the consistency required to run generative AI models around the clock, leaving nuclear energy as the most viable long-term solution. This macroeconomic shift creates a generational tailwind for businesses that supply the physical hardware enabling advanced nuclear power.

BWX Technologies (NYSE: BWXT)recently made a decisive move to dominate this space. By reaching a definitive agreement to sell its medical isotopes business to Nordic Capital for up to $800 million, BWX Technologies is stripping away non-core assets to become a hyper-focused, pure-play nuclear energy and defense contractor. The strategic pivot strengthens the balance sheet by providing immediate liquidity, capital needed to scale small modular reactor production and expand naval propulsion output.

Weaponizing Liquidity: An $800M Atomic Pivot

BWX Technologies originally acquired its medical isotopes division in 2018, steadily growing the unit and tripling its revenue over the last several years. While highly accretive, the medical segment ultimately operated tangentially to the primary competency of building nuclear reactors and propulsion components.

Offloading this division to Nordic Capital is a strategic masterstroke in capital allocation. It generates a cash injection of up to $800 million that can be deployed directly into national security operations and commercial nuclear power expansion without tapping high-cost debt markets.

The deal’s structure also provides a safety net. Management retained a minority ownership stake in the divested medical entity, ensuring shareholders still capture some upside in the rapidly growing radiopharmaceutical market. The primary operational focus is now firmly on the nuclear renaissance.

Critical Mass: A Backlog Built for the Next Decade

Looking at the second-quarter earnings report from August 2026, the pivot toward commercial nuclear applications is already executing at scale. Commercial operations revenue surged 72% year-over-year to $302.5 million. This breakout growth validates the strategy to concentrate resources on heavy nuclear infrastructure. Total revenue for BWX Technologies reached about $901 million, an 18% increase from the same quarter last year.

Total backlog swelled to around $8.39 billion, up from $6.01 billion in the second quarter of 2025. A backlog of this magnitude insulates the balance sheet against near-term economic volatility. It provides long-term cash flow predictability, allowing management to confidently forecast revenue and allocate resources years into the future.

To further support this commercial expansion, BWX Technologies closed its acquisition of Precision Components Group, announced on July 6, 2026. This acquisition instantly scales domestic manufacturing capacity, establishing a dedicated U.S. footprint specifically designed for commercial nuclear component production.

Controlling the manufacturing supply chain is a critical advantage as global demand for nuclear hardware accelerates. Precision Components Group brings specialized welding and machining capabilities that directly complement existing naval nuclear operations, creating operational savings that should begin reflecting in operating margins over the next several quarters.

How SMRs Will Fuel the Future

The broader market is just beginning to understand the severe energy demands of the artificial intelligence data center build-out. Regional power grids are already feeling the strain, forcing utility operators to rethink their long-term capacity models. Small modular reactors offer a scalable, factory-built solution that can be deployed faster and cheaper than traditional large-scale nuclear plants.

Because of its deep history supplying nuclear propulsion systems to the U.S. Navy, BWX Technologies already possesses the specialized engineering talent, regulatory clearances, and heavy manufacturing facilities required to dominate the small modular reactor supply chain.

The capital injection from the medical divestiture will fund the necessary capacity expansion to meet this impending wave of commercial demand. Institutional infrastructure funds and clean energy portfolios are increasingly recognizing nuclear power as a necessary component of the energy transition, creating a structural bid for pure-play nuclear equities. As data center operators begin signing long-term purchase agreements for nuclear baseload power, businesses that produce the core components of nuclear reactors are positioned to capture a large share of the value chain.

Half-Life of a Pullback: Why Fundamentals Win Out

Despite strong fundamentals and raised forward guidance, BWX Technologies has experienced a roughly 9% pullback over the past 30 days. Currently trading near $172, this margin compression appears strictly tied to broader market rotations rather than any underlying fundamental weakness. Insiders have executed some net selling, but given the equity’s 225% appreciation over the trailing five years, this distribution aligns with standard executive profit-taking rather than internal distress.

The underlying financials tell a story of balance sheet health. Post-earnings, management raised the 2026 earnings before interest, taxes, depreciation, and amortization guidance to a range of $662 million to $672 million. Non-GAAP earnings per share forecasts were bumped to $4.70 to $4.80. BWX Technologies also raised its free cash flow outlook to $345 million to $360 million.

Sustaining capital returns while orchestrating a structural divestiture is a clear signal of confidence. Management maintained the regular quarterly dividend of 27 cents per share, payable on Sept. 4, 2026. Wall Street is taking notice of these robust cash flows. BTIG reiterated a Buy ratingimmediately following the earnings release, maintaining a $235 price target. This target implies an upside of roughly 35% from current levels.

The Final Countdown: Positioning for the Nuclear Age

The transition into a pure-play nuclear defense and commercial power supplier removes a layer of complexity from the business model. Investors no longer have to model out the intricacies of the medical radioisotope market when valuing BWX Technologies. The investment thesis is now cleanly tied to the global expansion of nuclear energy and a growing defense budget.

While the trailing price-to-earnings ratio sits around 47, the forward multiple contracts to about 38, reflecting the earnings growth expected in the back half of the decade. Investors must recognize that small modular reactor deployment timelines remain relatively long, and regulatory hurdles could delay some commercial projects. Any execution missteps in integrating Precision Components Group or expanding existing facilities could temporarily weigh on margins.

Investors looking to capitalize on the widening energy deficit created by artificial intelligence data centers might want to add BWX Technologies to their watchlist as commercial nuclear demand accelerates. Cautious investors may prefer to wait for BWX Technologies to establish a firm base around the $170 level before taking a position, keeping a close eye on the upcoming close of the Nordic Capital transaction. READ THIS STORY ONLINE

Elon moved first. I bought 10,000 shares. (Ad)

Tesla just signed a six-year supply agreement with a small nickel producer trading around $5 a share. The company controls what may be the most important domestic nickel operation in the U.S., backed by government support and a legendary mining billionaire.

One of the world’s largest mining companies is already working alongside it, yet Wall Street has barely noticed. Dr. Mark Skousen says he’s already put his own money into 10,000 shares.SEE THE OVERLOOKED NICKEL STOCK BEHIND TESLA’S SUPPLY DEAL

More Stories

• System Upgrade: First Internet Bancorp Options Surge
• Palantir Soars 30% After Blockbuster Earnings—Is the Rally Just Getting Started?
• Why Wall Street Is Ignoring This Small Space Stock Near SpaceX(Ad)
• Caterpillar’s Record Quarter May Have Reset the Stock’s Ceiling
• 3 Stocks Taking Very Different Routes Through the Summer Rally
• AMD’s Post-Earnings Drop May Be the Opportunity Investors Wanted
• The Real Reason Amazon Hit a $3 Trillion Valuation

The Night Owl is a financial newsletter that provides in-depth market analysis on stocks of interest to individual investors. Published by MarketBeat and Early Bird Publishing, The Night Owl is delivered around 9:00 PM Eastern Sunday through Thursday. If you give a hoot about the market, The Night Owl is the newsletter for you.

View as a Web Page

If you have questions about your newsletter, please feel free to email our U.S. based support team at contact@marketbeat.com.

Unsubscribe

© 2006-2026 MarketBeat Media, LLC. All rights protected.
345 North Reid Place, Sixth Floor, Sioux Falls, S.D. 57103-7078. USA..

Link of the Day: Ray Dalio: Buy Gold. Get Paid.(From Investors Alley)